Skip to content

Evidence-Based Development of an Integrated Traditional Chinese and Western Medicine Perioperative Protocol for Colorectal Cancer and Its Empirical Study

Evidence-Based Development of an Integrated Traditional Chinese and Western Medicine Perioperative Protocol for Colorectal Cancer and Its Empirical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002010
Enrollment
Unknown
Registered
2025-10-22
Start date
2025-10-23
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Test group:Acupuncture treatment on the basis of an accelerated rehabilitation surgical programme
Control group:Routine Accelerated Rehabilitation Surgery Programme

Sponsors

Xiyuan Hospital China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age 18 to 75 years old, gender is not limited; (2) Pathological diagnosis of colorectal malignant tumour with stage II or III; (3) Patients who plan to use surgery for radical treatment; (4) Chinese medicine identification belongs to spleen deficiency; (5) Patients voluntarily participated in clinical observation and signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who were found to be incapable of radical excision intraoperatively; (2) Those with skin allergy, skin breakout and poor diabetic blood sugar control at the site of needling; (3) Combined serious heart, liver, kidney and other organs dysfunction patients; exclude blood diseases, immune diseases, other tumours patients; (4) Pregnant women and breastfeeding mothers; patients who plan to become pregnant; (5) Those who suffer from mental illness, or those who have difficulty in verbal communication and cannot complete this study; (6) Those who, in the opinion of the investigator, are not suitable for participation in this study. (7) Patients who participated in other studies in the last 1 month.

Design outcomes

Primary

MeasureTime frame
Postoperative venting time;

Secondary

MeasureTime frame
Postoperative defecation time;Postoperative urination time;Percentage of overall postoperative complications;Length of hospital stay (days) and hospitalization costs (RMB);Chinese Medicine Symptoms Scale for Spleen Deficiency;Health-related quality of life scores (EORTC QLQ-CR29 and C30 scales);12-Item Short Form Survey;Hamilton Anxiety Scale;Hamilton Depression Scale;

Countries

China

Contacts

Public ContactJia Xiaoqiang

Xiyuan Hospital of China Academy of Chinese Medical Sciences

jxq391@sina.com15110022677

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026